The cytopathology of serous effusions: The cavalry has arrived - With reinforcements

Current Diagnostic Pathology

Volumn 7, Issue 2, 2001, Pages 123-130

  Leiman, G ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

Cytopathology; Fluid cytology; Immunocytochemistry; Mesothelioma; Reactive mesothelial cells; Serous effusions

Indexed keywords

BIOCHEMICAL MARKER; CADHERIN; CALRETININ;

ADENOCARCINOMA; CELL PROLIFERATION; CELL STRUCTURE; CYTODIAGNOSIS; CYTOPATHOLOGY; DISEASE MARKER; EFFUSION; ELECTRON MICROSCOPY; HISTOCHEMISTRY; HUMAN; IMMUNOCHEMISTRY; MALIGNANT MESOTHELIOMA; MESOTHELIUM CELL; MICROSCOPY; PLOIDY; REVIEW;

EID: 0034924385     PISSN: 09686053     EISSN: None     Source Type: Journal    
DOI: 10.1054/cdip.2001.0068     Document Type: Review

References (61)

1. The malignant pleural effusion: A review of cytopathologic diagnoses of 584 specimens from 472 consecutive patients
2. Cells of squamous cell carcinoma in pleural, peritoneal and pericardial fluids: Origin and morphology
3. The clinical aspects of mesothelioma
4. Atypical mesothelial cells in peritoneal dialysis fluid
5. Diagnosis of pleural malignant mesothelioma in life - A practical approach
6. The cytologic diagnosis of mesothelioma
7. Cytopathology of malignant mesothelioma: A stepwise logistic regression analysis
8. The cytology of malignant mesothelioma
9. An intriguing finding in malignant effusions
10. Significance of pericellular lacunae in cell blocks of effusions
11. Pericellular lacunae in effusions
12. Diagnostic efficiency of carcinoembryonic antigen and CA125 in the cytological evaluation of effusions
13. Malignant epithelioid pleural mesothelioma versus peripheral pulmonary adenocarcinoma: A histochemical, ultrastructural and immunohistologic study of 103 cases
14. Immunopathologic and molecular studies as an aid to the diagnosis of malignant mesothelioma
15. The separation of benign and malignant mesothelial proliferations
16. Differential diagnosis between mesothelioma and adenocarcinoma: A multimodal approach based on ultrastructure and immunocytochemistry
17. The distinction of adenocarcinoma from malignant mesothelioma in cell blocks of effusions: The role of routine mucin histochemistry and immunohistochemical assessment of carcinoembryonic antigen, keratin proteins, epithelial membrane antigen and milk fat globule-derived antigen
18. Detection of adenocarcinoma in peritoneal washings by staining with monoclonal antibody B72.3
19. Distinction between carcinoma cells and mesothelial cells in serous effusions: Usefulness of immunocytochemistry
20. Markers for metastatic adenocarcinoma in serous effusion specimens
21. Immunohistochemical properties of malignant mesothelioma cells in histologic and cytologic specimens
22. Immunocytochemical staining of smears and corresponding cell blocks from serous effusions: A follow up and comparative investigation
23. Complementary value of five carcinoma markers for the diagnosis of malignant mesothelioma, adenocarcinoma metastasis, and reactive mesothelium in serous effusions
24. MOC-31 aids in the differentiation between adenocarcinoma and reactive mesothelial cells
25. Reactivity of six antibodies in effusions of mesothelioma, adenocarcinoma and mesotheliosis: Stepwise logistic regression analysis
26. Special stains, the old and the new: The impact of immunocytochemistry in effusion cytology
27. Epithelial membrane antigen - A diagnostic discriminant in surgical pathology
28. 'Thick' cell membranes revealed by immunocytochemical staining: A clue to the diagnosis of mesothelioma
29. Epithelial membrane antigen in the cytodiagnosis of effusions and aspirates: Immunocytochemical and ultrastructural localization in benign and malignant cells
30. The roles of immunohistochemistry and electron microscopy in distinguishing epithelial mesothelioma of the pleura from adenocarcinoma
31. Calretinin: A novel immunocytochemical marker for mesothelioma
32. The immunohistochemical diagnostic panel for epithelial mesothelioma
33. Calretinin: A novel tool for diagnostic immunohistochemistry
34. In search of a positive immunohistochemical marker for mesothelioma: An update
35. Calretinin: A selective marker of normal and neoplastic mesothelial cells in serous effusions
36. Calretinin staining pattern aids in the differentiation of mesothelioma from adenocarcinoma in serous effusions
37. Cytologic differential diagnosis among reactive mesothelial cells, malignant mesothelioma, and adenocarcinoma: Utility of combined E-cadherin and calretinin staining
38. Diagnostic utility of calretinin immunohistochemistry in cytologic cell block preparations
39. E-cadherin, N-cadherin, and calretinin in pleural effusions: The good, the bad and the worthless
40. Calretinin immunostaining in benign and malignant pleural effusions
41. Use of E-cadherin and CD44 aids in the differentiation between reactive mesothelial cells and carcinoma cells in pelvic washings
42. E-cadherin expression is a sensitive and specific method for detection of carcinoma cells in fluid specimens
43. N-cadherin distinguishes pleural mesotheliomas from lung adenocarcinomas - A ThinPrep® immunocytochemical study
44. Monoclonal antibody KI reacts with epithelial mesothelioma but not with lung adenocarcinoma
45. Utility of the antibodies Ca 19-9, HBME-I, and Thrombomodulin in the diagnosis of malignant mesothelioma and adenocarcinoma in cytology
46. Comparison of light and transmission electron microscopy for the evaluation of body cavity effusions
47. Ultrastructural histochemistry of mesotheliomas and adenocarcinoma in malignant effusions
48. Ultrastructure of pleural mesothelioma and pulmonary adenocarcinoma in malignant effusions as compared with reactive mesothelial cells
49. Flow cytometric DNA analysis versus cytology in the evaluation of peritoneal fluids
50. Prospective study of concurrent ploidy analysis and routine cytopathology in body cavity fluids
51. Role of DNA flow cytometry and image cytometry on effusion fluid
52. Detection of hyperdiploid malignant cells in body cavity effusions by fluorescence in-situ hybridization on ThinPrep slides
53. Epithelioid pleural mesotheliomas and pulmonary adenocarcinomas: A comparative DNA flow cytometric study
54. Flow cytometric analysis of ploidy in immunohistochemically confirmed examples of malignant epithelial mesothelioma
55. Detection of aneuploidy in mesothelioma cell lines by fluorescence in situ hybridization (FISH)
56. Diagnostic value of p53 protein and flow cytometric DNA analysis in the study of serous effusions
57. p53 immunostaining as a marker of malignancy in cytologic preparations of body fluids
58. DNA ploidy and proliferating cell nuclear antigen image analysis of peritoneal and pleural effusions
59. Improved detection of adenocarcinoma of serous fluids with p53 immunocytochemistry
60. Value of Ki67 immunostain in identification of malignancy in serous effusions
61. Differential diagnosis of malignant effusions